Jon P. Stonehouse
About Jon P. Stonehouse
Jon P. Stonehouse is the President and CEO with a background in microbiology and extensive experience in the pharmaceutical industry, including significant roles at Merck & Co., Inc. and Merck KGaA.
Jon P. Stonehouse Professional Background
Jon P. Stonehouse serves as the President and Chief Executive Officer. He began his career in the pharmaceutical industry as a sales representative. Over the years, he has progressed through varying sales leadership positions at Merck & Co., Inc. He later served as the Senior Vice President of Corporate Development for Merck KGaA, where he led strategic efforts that significantly impacted the company's direction.
Jon P. Stonehouse Education and Expertise
Jon P. Stonehouse earned a Bachelor of Science degree in Microbiology from the University of Minnesota. His academic background in microbiology has provided a strong foundation for his extensive career in the pharmaceutical and biopharmaceutical industries.
Jon P. Stonehouse Role at Merck KGaA
As the Senior Vice President of Corporate Development at Merck KGaA, Jon P. Stonehouse was instrumental in devising a strategy that led to fundamental changes within the company. One of his key achievements was leading the acquisition of Serono, S.A., which was pivotal in shaping the future of Merck KGaA.
Jon P. Stonehouse Advisory and Board Memberships
In 2011, Jon P. Stonehouse joined the advisory board of Genscript, a private bioservices company. In December 2014, he further extended his influence within the industry by joining the Board of Directors of Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on novel cellular immunotherapies.